Capillary Electrophoresis Market Revenue to Attain USD 1,080.08 Mn by 2035
Published: 22 Dec 2025
Author: Precedence Research
Capillary Electrophoresis Market Revenue and Trends 2026 to 2035
The global capillary electrophoresis market revenue surpassed USD 648.11 million in 2025 and is predicted to attain around USD 1,080.08 million by 2035, growing at a CAGR of 5.24%. This market is experiencing unprecedented growth, driven by the growing diagnostic demand, increasing emphasis on personalized medicines, and rapid technological innovation.
What Are the Factors That Have a Significant Contribution to the Growth of the Capillary Electrophoresis Market?
The rapid expansion of the biopharmaceutical sector and the rising burden of cancer, infectious diseases, and rare genetic diseases are the major drivers of the capillary electrophoresis market's growth during the forecast period. For instance, in February 2024, Sysmex Corporation and Hitachi High-Tech Corporation announced that they had agreed to collaborate on the development of genetic testing systems based on capillary electrophoresis sequencers (CE sequencers). The partnership aims to develop more efficient genetic testing systems at a lower cost, to expand optimal genetic testing for individual diseases.
The rapid technology advancements in capillary electrophoresis (CE) instruments, including microfluidic & microchip CE (MCE), multi-dimensional CE (MD-CE), and high-throughput systems, are likely to drive the market over the forecast period. Capillary electrophoresis (CE) is widely adopted in drug discovery, pharmacokinetics, and biomarker identification for separating complex mixtures of biomolecules. Additionally, the massive R&D investment in drug discovery, growing demand for tailored treatments, and stringent regulatory mandates are expected to fuel the expansion of the capillary electrophoresis market.
Segment Insights
- By product type, the capillary electrophoresis systems segment held the largest market share of 58.8% in 2025, owing to the increasing demand from the biotechnology, pharmaceutical, and clinical diagnostics industries. The capillary electrophoresis systems provide high-resolution separation, fast analysis, and accurate quantification of biomolecules.
- By technique, the capillary zone electrophoresis (CZE) segment led the market, accounting for an estimated 42.5% share in 2025. The flexibility, reliability, and versatility of capillary zone electrophoresis (CZE) make it the most widely used technique in pharmaceutical and clinical applications.
- By end-user, the pharmaceutical & biotechnology companies segment accounted for the largest share, 35.5%, in 2025. Pharmaceutical & biotechnology companies increasingly rely on capillary electrophoresis for characterization of biologics, monoclonal antibodies, and recombinant proteins, quality control, lot-release testing, and others.
- By application, the drug development & QC segment held a dominant 38.9% share in 2025. The continuous growth of gene therapies, biologics, and biosimilars has significantly increased the usage of capillary electrophoresis in drug development and QC processes.
Regional Insights
North America holds the dominant share in the global capillary electrophoresis market. The region’s leadership is driven by the owing to its presence of sophisticated healthcare infrastructure, rapid technological advancement in capillary electrophoresis instrumentation, the growing need for automation to address labor shortages, strict regulatory compliance for quality control, the increasing emphasis on personalized medicine, and the surge in chronic diseases. Moreover, the rising demand for biologics and biosimilars and increased funding for genomics and proteomics research are expected to drive growth in the capillary electrophoresis market during the forecast period. Such a combination of factors is likely to fuel the region's expansion in the coming years.
On the other hand, the Asia Pacific region is anticipated to grow at the fastest rate in the market during the forecast period. The region's fastest growth is attributed to rapid technological progress, a rising number of clinical laboratories, a surge in R&D funding, a supportive government framework, a growing demand for personalized medicine, and an increasing patient population with chronic diseases.
Capillary Electrophoresis Market Coverage
| Report Attribute | Key Statistics |
| Market Revenue in 2025 | USD 648.11 Million |
| Market Revenue by 2035 | USD 1,080.08 Million |
| CAGR from 2026 to 2035 | 5.24% |
| Quantitative Units | Revenue in USD million/billion, Volume in units |
| Largest Market | North America |
| Base Year | 2025 |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa |
Recent Developments
- In May 2025, Thermo Fisher Scientific introduced the Applied Biosystems SeqStudio Flex Dx genetic analyzer, an IVDR-compliant capillary electrophoresis system for Sanger sequencing and fragment analysis in targeted genomic testing. The system includes three operating modes: in vitro diagnostic use, investigational use only, and research use only. It is available in eight- and 24-capillary configurations.(Source: https://www.captodayonline.com)
Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/7221
You can place an order or ask any questions, please feel free to contact us at sales@precedenceresearch.com |+1 804 441 9344